<p>Estimated proportion of warfarin benefit by new oral anticoagulants on the risk of stroke.</p
Objectives. (1) To develop a probability trade-off technique (PTOT) for determining the minimal clin...
The NOAC group showed lower risks of safety and composite outcome to the warfarin group with TTR of ...
Contains fulltext : 87207.pdf (publisher's version ) (Closed access)Warfarin reduc...
<p>Estimated proportion of warfarin benefit by new oral anticoagulants on the risk of stroke.</p
<p>Estimated proportion of warfarin benefit by new oral anticoagulants on the risk of all-cause mort...
The adjusted risk of outcomes for those patients taking oral anticoagulants in relative to no-treatm...
Introduction the known benefit of warfarin, appropriate medication use range from 34 to 43 % of peut...
Background: Guidelines recommend warfarin use in patients with atrial fibrillation solely on the bas...
<p>Annual incidence of new occurrence of CAD with different presentations comparing amongst differen...
<p>Only endpoints available in all studies are reported. NOAC = new oral anticoagulant drug; BID ...
<p>Forest plot of pooled odds ratios (with 95% CI) of various efficacy outcomes for FDA-approved dir...
This study quantitatively evaluated the comparative efficacy and safety of new oral anticoagulants (...
Background: Anticoagulation with warfarin reduces the risk of ischaemic stroke in patients with atri...
<p>Forest plot of pooled odds ratios (with 95% CI) of various adverse drug events for FDA-approved d...
Warfarin and new oral anticoagulants are effective in reducing stroke in atrial fibrillation; howeve...
Objectives. (1) To develop a probability trade-off technique (PTOT) for determining the minimal clin...
The NOAC group showed lower risks of safety and composite outcome to the warfarin group with TTR of ...
Contains fulltext : 87207.pdf (publisher's version ) (Closed access)Warfarin reduc...
<p>Estimated proportion of warfarin benefit by new oral anticoagulants on the risk of stroke.</p
<p>Estimated proportion of warfarin benefit by new oral anticoagulants on the risk of all-cause mort...
The adjusted risk of outcomes for those patients taking oral anticoagulants in relative to no-treatm...
Introduction the known benefit of warfarin, appropriate medication use range from 34 to 43 % of peut...
Background: Guidelines recommend warfarin use in patients with atrial fibrillation solely on the bas...
<p>Annual incidence of new occurrence of CAD with different presentations comparing amongst differen...
<p>Only endpoints available in all studies are reported. NOAC = new oral anticoagulant drug; BID ...
<p>Forest plot of pooled odds ratios (with 95% CI) of various efficacy outcomes for FDA-approved dir...
This study quantitatively evaluated the comparative efficacy and safety of new oral anticoagulants (...
Background: Anticoagulation with warfarin reduces the risk of ischaemic stroke in patients with atri...
<p>Forest plot of pooled odds ratios (with 95% CI) of various adverse drug events for FDA-approved d...
Warfarin and new oral anticoagulants are effective in reducing stroke in atrial fibrillation; howeve...
Objectives. (1) To develop a probability trade-off technique (PTOT) for determining the minimal clin...
The NOAC group showed lower risks of safety and composite outcome to the warfarin group with TTR of ...
Contains fulltext : 87207.pdf (publisher's version ) (Closed access)Warfarin reduc...
DOI
Add to ORKG